Our results reveal that BLM treatment induces substantial DNA damage and promotes CD8+ T cell activation through the specific upregulation of MHC-I expression in an ATM/ATR–NF-κB–dependent manner. The gene discussed is ATM; the disease is Bloom syndrome.